Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Plos One
|
May 19, 2011
Plasma proteome profiles associated with inflammation, angiogenesis, and cancer
Karen S Kelly-Spratt, Sharon J Pitteri, Kay E Gurley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 25, 2013
A novel soluble form of Tim-3 associated with severe graft-versus-host disease
John A Hansen, Samir M Hanash, Laura Tabellini, et al.
Cancer Research
|
December 28, 2012
Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women
Jon J Ladd, Timothy Chao, Melissa M Johnson, et al.
Cancer Research
|
June 10, 2011
Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression
Sharon J Pitteri, Karen S Kelly-Spratt, Kay E Gurley, et al.
Cancer Research
|
June 28, 2014
A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets
Ayumu Taguchi, Allen D Taylor, Jaime Rodriguez, et al.
Cancer Research
|
October 21, 2010
Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users
Sharon J Pitteri, Lynn M Amon, Tina Busald Buson, et al.
Blood
|
October 8, 2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
James L M Ferrara, Andrew C Harris, Joel K Greenson, et al.
Molecular & Cellular Proteomics : MCP
|
September 25, 2012
Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity
Carolina H Thomé, Guilherme A dos Santos, Germano A Ferreira, et al.
The New England Journal of Medicine
|
August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
Mark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Science Translational Medicine
|
April 8, 2010
Elafin is a biomarker of graft-versus-host disease of the skin
Sophie Paczesny, Thomas M Braun, John E Levine, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Plos One
|
May 19, 2011
Plasma proteome profiles associated with inflammation, angiogenesis, and cancer
Karen S Kelly-Spratt, Sharon J Pitteri, Kay E Gurley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 25, 2013
A novel soluble form of Tim-3 associated with severe graft-versus-host disease
John A Hansen, Samir M Hanash, Laura Tabellini, et al.
Cancer Research
|
December 28, 2012
Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women
Jon J Ladd, Timothy Chao, Melissa M Johnson, et al.
Cancer Research
|
June 10, 2011
Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression
Sharon J Pitteri, Karen S Kelly-Spratt, Kay E Gurley, et al.
Cancer Research
|
June 28, 2014
A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets
Ayumu Taguchi, Allen D Taylor, Jaime Rodriguez, et al.
Cancer Research
|
October 21, 2010
Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users
Sharon J Pitteri, Lynn M Amon, Tina Busald Buson, et al.
Blood
|
October 8, 2011
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease
James L M Ferrara, Andrew C Harris, Joel K Greenson, et al.
Molecular & Cellular Proteomics : MCP
|
September 25, 2012
Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity
Carolina H Thomé, Guilherme A dos Santos, Germano A Ferreira, et al.
The New England Journal of Medicine
|
August 9, 2013
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death
Mark T Vander Lugt, Thomas M Braun, Samir Hanash, et al.
Science Translational Medicine
|
April 8, 2010
Elafin is a biomarker of graft-versus-host disease of the skin
Sophie Paczesny, Thomas M Braun, John E Levine, et al.
Page
of 3